S. Snapinn, M. Chen, Q. Jiang, und T. Koutsoukos. Pharmaceutical statistics, 5 (4):
273-81(2006)7401<m:linebreak></m:linebreak>LR: 20071115; JID: 101201192; ppublish;<m:linebreak></m:linebreak>Mesures de contrast; RCT.
A. Rid, und D. Wendler. Kennedy Institute of Ethics journal, 21 (2):
141-79(Juni 2011)6275<m:linebreak></m:linebreak>JID: 9109135; ppublish; Consultar-lo a la web (40 pàgines!)<m:linebreak></m:linebreak>Relació benefici/risc.
B. Djulbegovic. The Journal of medicine and philosophy, 32 (2):
79-98(2007)7494<m:linebreak></m:linebreak>LR: 20071115; GR: 1 R01 NS044417-01/NS/NINDS NIH HHS/United States; JID: 7610512; ppublish;<m:linebreak></m:linebreak>Intervenció/placebo; Recerca clínica; Ètica;.
M. Angell. JAMA : the journal of the American Medical Association, 300 (9):
1069-71(September 2008)4723<m:linebreak></m:linebreak>JID: 7501160; ppublish;<m:linebreak></m:linebreak>Recursos/Organització; Recerca clínica.
S. Halpern, J. Karlawish, und J. Berlin. JAMA : the journal of the American Medical Association, 288 (3):
358-62(Juli 2002)3459<m:linebreak></m:linebreak>Mesures de contrast.
K. Taylor, R. Margolese, und C. Soskolne. The New England journal of medicine, 310 (21):
1363-7(Mai 1984)5954<m:linebreak></m:linebreak>LR: 20071115; JID: 0255562; ppublish;<m:linebreak></m:linebreak>Intervenció/placebo.
B. Djulbegovic, und M. Clarke. JAMA : the journal of the American Medical Association, 285 (9):
1206-8(März 2001)2678<m:linebreak></m:linebreak>JAMA. 2001 Mar 7;285(9):1155-63.;<m:linebreak></m:linebreak>Tests d'equivalència.